This is a specific medicine that combines two drugs: budesonide and formoterol. It's used to treat asthma and COPD. It helps open up the airways to make breathing easier.
Every report comes from a Lived member, sent anonymously.
Have you tried Symbicort (Budesonide / Formoterol) for Asthma?
Symbicort is a prescription inhaler that combines two medicines: budesonide, an inhaled corticosteroid that calms inflammation in the airways, and formoterol, a long-acting bronchodilator that keeps the airways open. The same combination is also sold as Breyna and as unbranded generic inhalers. It is approved in the US for two conditions. In asthma, it is used by adults and children 6 and older whose asthma is not well controlled on an inhaled steroid alone, or whose asthma is severe enough to start with both medicines at once. In chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and emphysema, it is used by adults as a daily maintenance treatment to ease breathing and reduce flare-ups. Only the higher strength (160/4.5) is approved for COPD. US asthma guidelines also recommend using one budesonide-formoterol inhaler as both the daily controller and the reliever for symptoms, an approach called single maintenance and reliever therapy (SMART), for many people with moderate to severe asthma aged 4 and older. This use is outside the US label, so it applies only when a prescriber sets up that plan specifically.
Asthma and COPD both narrow the airways, but in two different ways that this inhaler addresses separately. Inflammation makes the airway lining swollen, irritable and quick to react to triggers. Budesonide, a corticosteroid, works on that inflammation over days to weeks, making the airways less reactive and flare-ups less likely. Because it is inhaled, most of its effect stays in the lungs, with much less reaching the rest of the body than steroid tablets. The second problem is tightening of the muscle that wraps around the airways. Formoterol is a long-acting beta2-agonist (LABA), a medicine that relaxes that muscle and opens the airways within minutes, with effects lasting about 12 hours. The two parts matter together: a LABA used on its own for asthma raises the risk of severe and even fatal attacks, while combining it with an inhaled steroid in one inhaler has not shown that increase in large safety trials.
Symbicort is a metered-dose inhaler that comes in two strengths, 80/4.5 and 160/4.5, which describe the micrograms of budesonide and formoterol in each puff. The usual label dose is 2 puffs twice a day, morning and evening, about 12 hours apart, every day whether or not symptoms are present. Children 6 to 11 use the lower strength. Shake the inhaler before each puff, and prime it with two test sprays into the air when it is new, has been dropped or has not been used for more than a week. After each dose, rinse the mouth with water and spit it out. This removes steroid left in the mouth and throat and lowers the chance of thrush, a yeast infection that causes white patches. On the standard label plan, Symbicort is not a rescue inhaler. Sudden symptoms are treated with a separate fast-acting reliever such as albuterol, so keep one available. Taking extra Symbicort puffs beyond the prescribed dose on this plan is not recommended. On a SMART plan, the prescriber instead tells the person to take 1 or 2 extra puffs of the same inhaler when symptoms come on. Guidelines cap the total at 12 puffs a day for people 12 and older and 8 puffs a day for children 4 to 11. The two plans use the inhaler very differently, so it matters to know which one has been prescribed.
The most common side effects are cold-like symptoms, headache, sore throat or hoarseness, sinus infections and an upset stomach. Thrush in the mouth or throat is more likely with inhaled steroids; white patches or soreness are worth reporting, as thrush is easily treated and rinsing after each dose helps prevent it. The formoterol part can cause a fast or pounding heartbeat, tremor or nervousness, especially at higher doses. People with COPD who use inhaled steroids have a higher risk of pneumonia, and its signs can look like a COPD flare. Fever, chills, a change in the color of mucus or a worsening cough or breathlessness should prompt a call to the care team the same day. Two breathing problems need prompt action. Rarely, the airways tighten right after a dose, causing wheezing or difficulty breathing instead of relief. If that happens, use the rescue inhaler, do not use Symbicort again until the prescriber has advised, and contact the prescriber right away; if breathing does not improve with the rescue inhaler, get emergency care. Separately, needing the rescue inhaler more often than usual, or finding it helps less, is a sign that asthma or COPD is getting worse and needs medical review right away rather than at the next routine visit.
Do not use any other long-acting bronchodilator of the same type, such as salmeterol (found in Advair and Serevent) or a separate formoterol or arformoterol product, while using Symbicort. Doubling up raises the risk of heart rhythm problems and other effects of too much beta-agonist. Beta-blockers, a group of heart and blood pressure medicines that also includes some glaucoma eye drops, can block formoterol's effect and trigger severe airway tightening in people with asthma, so any new prescription should be checked against the inhaler. Ritonavir, an HIV medicine, and certain strong antifungal medicines and antibiotics can raise budesonide levels in the body and increase steroid side effects. Water pills that lower potassium can add to formoterol's effect on potassium and heart rhythm. Anyone switching from steroid tablets such as prednisone to Symbicort needs a slow taper of the tablets under medical guidance, because the body's own steroid production may take time to recover, and stopping tablets abruptly can be dangerous. Inhaled steroids slightly weaken some immune defenses. People who have never had chickenpox or measles and are not vaccinated should contact their clinician promptly after an exposure. Long-term use can contribute to bone thinning, cataracts and glaucoma, and can slightly slow growth in children, so people with osteoporosis risk, eye disease, heart rhythm problems, diabetes, seizures or an overactive thyroid should make sure the prescriber knows. In pregnancy, studies of inhaled budesonide have not shown an increase in birth defects, while poorly controlled asthma carries its own risks for both parent and baby. The decision to continue is best made with the care team rather than by stopping on one's own.
Breathing can start to ease within about 15 minutes of the first dose because formoterol acts quickly, but the full benefit of the steroid builds over 2 weeks or longer. Response varies, and if control is still poor after a couple of weeks, the prescriber may move to the higher strength or reconsider the plan. Symbicort controls asthma and COPD but does not cure them. Symptoms often return if it is stopped, so it is usually continued even on good days, and any change or step-down is done with the prescriber. Good inhaler technique makes a large difference to how much medicine reaches the lungs, so it is worth having a clinician or pharmacist check it, especially early on. Follow-up focuses on symptoms, flare-ups, how often the rescue inhaler is needed, and sometimes breathing tests. With long-term use, the care team may also suggest periodic eye exams, attention to bone health, and growth checks for children.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Symbicort (Budesonide / Formoterol), what you've noticed, or ask the community a question.